Transact Technologies TACT Concentration Risk %

Discontinued — last reported Q4 '15

Concentration Risk % at other companies

IdentiveINVE

10.3%+7.7pp

Heartland ExpressHTLD

32%+6.0pp

Enovix CorporationENVX

83%+36.0pp

RF IndustriesRFIL

100%0.0pp

Weis MarketsWMK

100%0.0pp

Gyre Therapeutics, Inc.GYRE

93.1%-5.3pp

Segments

By geography

See full

Europe59%+7.3%

Pacific Rim28%-17.6%

Non Us18%—

Other financials

Income statement

See full

Revenue$14.4M+10.4%

Gross profit$7.3M+14.1%

Operating income$771.0K+5,240%

Net income$766.0K+3,932%

EPS (diluted)$0.07—

Balance sheet

See full

Cash & equivalents$18.8M+32.9%

Total debt$3.4M+255%

Total equity$32.3M+4.4%

Total assets$47.9M+8.4%

Cash flow

See full

Operating cash flow-$946.0K-488%

CapEx$80.0K+700%

Free cash flow-$1.0M-500%

Valuation

See full

Market cap$60.01M+42.0%

Enterprise value$44.54M+86.4%

P/S1.1×+0.3×

Profitability

See full

Gross margin49%+0.5pp

Operating margin-1.2%-0.5pp

Net margin-0.9%-0.5pp

FCF margin12.7%—

Returns & leverage

See full

Return on equity-1.6%-0.8pp

Debt / equity0.1×+0.1×

Current ratio3.1×+0.1×

Where this comes from

Reported directly by Transact Technologies in its filing.

Tagged under the XBRL concept us-gaap:ConcentrationRiskPercentage1.

The official record: Transact Technologies’s 10-K, filed March 11, 2016, on SEC EDGAR. View the filing →